Maria Mar Hernandez Guillamon

Senior Researcher, Neurovascular Research Lab, VHIR.

Instituciones de las que forman parte

Investigador/a principal
Enfermedades Neurovasculares

Vall Hebron Institut de Recerca

Maria Mar Hernandez Guillamon

Instituciones de las que forman parte

Investigador/a principal
Enfermedades Neurovasculares

Vall Hebron Institut de Recerca

Senior Researcher, Neurovascular Research Lab, VHIR.

Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.

Proyectos

Grup de Recerca en Malalties Neurovasculars

IP: Joan Montaner Villalonga
Colaboradores: Raquel Arias Gonzalez, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Manuel Quintana Luque
Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca
Financiación: 46800
Referencia: 2009 SGR 432
Duración: 01/01/2010 - 30/04/2014

Estrategias para mejorar la eficacia y seguridad del tratamiento con Simvastatina en la Fase Aguda del Ictus Isquémico: STARS trial

IP: Joan Montaner Villalonga
Colaboradores: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Estevo Santamarina Pérez
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 175450
Referencia: EC07/90195
Duración: 01/11/2007 - 30/06/2012

Estudio sobre las causas que originan diferencias de género en la enfermedad neurovascular ¿Es el Ictus una patología machista?

IP: Joan Montaner Villalonga
Colaboradores: Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 41910
Referencia: MD07/00209
Duración: 01/01/2008 - 31/05/2009

European Stroke Research Network (EUSTROKE) Grant Agreement Nº 202213

IP: Joan Montaner Villalonga
Colaboradores: José Alvarez Sabin, Maria Mar Hernandez Guillamon, Carlos Molina Cateriano, Anna Rosell Novel
Entidad financiadora: EUROPEAN COMMISSION
Financiación: 463200
Referencia: EUSTROKE_FP7HEALTH2007
Duración: 01/03/2008 - 31/08/2013